H.C. Wainwright initiated coverage on Horizon Pharma with a new price target

11/1/22 7:30:31 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

H.C. Wainwright initiated coverage of Horizon Pharma with a rating of Neutral and set a new price target of $74.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$HZNP

Date	Price Target	Rating	Analyst
11/1/2022	$74.00	Neutral	H.C. Wainwright
8/4/2022		Outperform → Mkt Perform	SVB Leerink
6/14/2022	$139.00	Buy	UBS
6/6/2022	$95.00	Mkt Perform	SVB Leerink
5/23/2022	$95.00	Mkt Perform	SVB Leerink
3/15/2022	$140.00	Outperform	Oppenheimer
3/2/2022	$135.00 → $140.00	Overweight	Morgan Stanley
12/8/2021	$137.00	Overweight	Wells Fargo